Call for applications to support the development of new vaccine candidates against known high-risk pathogens and viral families. This initiative aims to accelerate the creation of exemplar vaccines for prototype viruses to establish a library against future threats like Disease X. Funding is available through three mechanisms: the Exploratory Award, offering up to US $1M over 18 months for early-stage testing; the Preclinical Development Award, providing up to US $5M to demonstrate preclinical proof of concept; and the Clinical Development Award, which supports clinical testing up to Phase III.
To view calls for proposals, a subscription is required. Members get full access to our grant database and receive 2-3 updates on new opportunities every week.
Already a member? Log in here to access all funding opportunities available on the portal.
Not a member yet? Subscribe to the EU Funding Portal Membership, and gain full access to all funding opportunities on the portal.